Skip to main content

Jumping Genes

Bacterial 'jumping genes' can target and control chromosome ends


Transposons, or "jumping genes"—DNA segments that can move from one part of the genome to another—are key to bacterial evolution and the development of antibiotic resistance. Cornell University researchers have discovered a new mechanism these genes use to survive and propagate in bacteria with linear DNA, with applications in biotechnology and drug development.

In a paper published in Science, researchers show that transposons can target and insert themselves at the ends of linear chromosomes, called telomeres, within their bacterial host. In Streptomyces—historically one of the most significant bacteria for antibiotic development—they found that transposons controlled the telomeres in nearly a third of the chromosomes.

"This is a big part of their biology," said senior author Joseph Peters, professor of microbiology. "Bacteria are like these little tinkerers. They're always collecting these mobile DNA pieces, and they're making new functions all the time—everything in antibiotic resistance is really about mobile genetic elements and almost always transposons that can move between bacteria."

With some technologies not available even five years ago, the researchers identified several families of transposons in cyanobacteria and Streptomyces that, using different mechanisms, can find and insert themselves at the telomere, with benefits for the transposon and their bacterial host.

For one, inserting at the end of the chromosome helps the transposon avoid genes for the cell's core functioning, which reside in the middle of the chromosomes; transposons that can target the ends are less likely to disrupt an essential function or cause cell death.

"If you could target the end, you're less likely to knock out something that the host wants, and then these ends, by various systems, are transferred between cells," Peters said.

"For any element to survive—a transposon, bacteria—they really need to be able to do those two things: they need to not cause too much damage, and they need a way to move to new hosts. By inserting into the telomeres, they're able to do both."

Transposons have been found clustered at the chromosome ends in eukaryotic cells, but this is the first time it's been documented in bacteria with linear chromosomes, and the researchers found that bacterial transposons (versus eukaryotes) use unique mechanisms to control the telomeres.

Transposons are usually flanked by protein-binding sequences that indicate where to excise the DNA element and move it to a new location. In Streptomyces, researchers observed that the transposons at the telomeres were one-sided, with a traditional transposon sequence on one end with the other end being the telomere. This functionally allows the transposon to be the telomere, making it essential to the cell generally.

"What it lets them do is become essential to the host, because they now control the telomere, and if the element got deleted along with this system, the host would die," Peters said.

The researchers found one subfamily of telomere-targeting transposons that coopted a CRISPR system—normally used by bacteria to defend against viruses—to target and insert itself into the chromosome ends. This process is further confirmation of previous research in Peters' lab that found transposons using CRISPR systems to move around genomes, opening the potential for a new gene-editing tool that would allow for larger sections of DNA to be inserted than the now widely used CRISPR-Cas9.

"The transposons keep grabbing these systems and coopting them in different ways," Peters said. "In this paper, we explained a new one of these elements using a CRISPR-Cas system to target the telomeres."

The insights—especially into Streptomyces, which is difficult to manipulate in the lab and accounts for the discovery of many of our antibiotics—could prove useful for drug development, as transposons drive bacterial evolution and may direct researchers to new antibiotics and other useful products encoded on these transposons.

"Most of life on the planet is microbes, and specifically bacteria," Peters said. "We want to understand how these living organisms function, but then we want to see how we can use these systems for the betterment of humankind."

Gene expression, Genetic mutation, DNA sequencing, Genome mapping, Epigenetics, CRISPR technology, Gene therapy, Genetic variation, Transcription factors, Molecular genetics, RNA interference, Genetic engineering, Genomic stability, Inherited disorders, Chromosome structure, Functional genomics, Genetic polymorphism, Non-coding RNA, Epigenetic regulation, Gene regulation

#GeneExpression #GeneticMutation #DNASequencing #GenomeMapping #Epigenetics #CRISPR #GeneTherapy #GeneticVariation #TranscriptionFactors #MolecularGenetics #RNAi #GeneticEngineering #GenomicStability #InheritedDisorders #ChromosomeStructure #FunctionalGenomics #GeneticPolymorphism #NonCodingRNA #EpigeneticRegulation #GeneRegulation

International Conference on Genetics and Genomics of Diseases

Visit: genetics-conferences.healthcarek.com

Award Nomination: genetics-conferences.healthcarek.com/award-nomination/?ecategory=Awards&rcategory=Awardee

Award registration: genetics-conferences.healthcarek.com/award-registration/

For Enquiries: contact@healthcarek.com

Get Connected Here
---------------------------------
---------------------------------
in.pinterest.com/Dorita0211
twitter.com/Dorita_02_11_
facebook.com/profile.php?id=61555903296992
instagram.com/p/C4ukfcOsK36
genetics-awards.blogspot.com/
youtube.com/@GeneticsHealthcare

Comments

Popular posts from this blog

Genetics role in ovarian cancer

The Medical Minute: Genetics play big role in ovarian cancer In 2024, about 19,680 women in the United States will receive a new diagnosis of ovarian cancer and 12,740 women will die from the disease, said Dr. Shaina Bruce , a gynecologic oncologist at Penn State Cancer Institute . The median age of all patients who develop ovarian cancer is 63. Historically, women at increased risk for ovarian cancer are recommended to have their fallopian tubes and ovaries removed when they have completed having children. Taking that step to protect themselves comes at a heavy price ― surgical menopause. But Bruce said medical science is catching up with ovarian cancer. Studies could lead to new methods for preventative care and the surgery needed to lower risk may be easier than it once was. Below, during Gynecologic Cancer Awareness Month, Bruce discusses the disease and why acting to reduce your risk is worth it. What’s the connection between heredity and ovarian cancer? About 25% of all cases of ...

Multifactorial Genetic Conditions

Multifactorial Genetic Conditions Multifactorial genetic conditions are disorders caused by the combined effects of multiple genes and environmental factors , rather than a single gene mutation . These conditions do not follow classic Mendelian inheritance patterns and instead result from complex gene–environment interactions . Factors such as lifestyle, nutrition, infections, stress, and exposure to toxins can significantly influence disease onset and severity in genetically susceptible individuals. Common examples include diabetes, cardiovascular diseases , neural tube defects, asthma, and many neuropsychiatric disorders. Understanding multifactorial inheritance is essential for risk prediction, preventive medicine, and personalized healthcare strategies. Multifactorial inheritance, polygenic traits, gene–environment interaction, complex diseases, genetic susceptibility, environmental risk factors, non-Mendelian inheritance, disease predisposition, polygenic risk score, precision ...

X chromosome

Gene on the X chromosome may help explain high multiple sclerosis rates in women Brain inflammation may be fueled by a gene on the X chromosome, a new study in mice suggests. And in female mice, who carry two X chromosomes, a diabetes drug called metformin may work to counteract that inflammation. If these findings bear out in later studies, they could help to unravel the long-standing mystery of why women, who have two copies of this inflammation-driving gene, are more prone to certain autoimmune diseases, particularly after menopause. A disparity between the sexes Our bodies are patrolled by immune cells that provide protection against bacteria and viruses, but sometimes, these defenses turn on us. In the autoimmune disorder multiple sclerosis (MS), for instance, the immune system attacks myelin, the fatty insulation surrounding the nerve fibers in the brain and spinal cord. This leads to symptoms such as muscle weakness and difficulty walking, as well issues with memory and thinking...